VOR — Vor Biopharma Balance Sheet
0.000.00%
- $82.58m
- -$9.35m
- 12
- 37
- 17
- 10
Annual balance sheet for Vor Biopharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 48.5 | 207 | 230 | 137 | 91.9 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 49.1 | 214 | 237 | 141 | 96.5 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 21.8 | 22.5 | 57.1 | 50.1 | 41.6 |
Other Long Term Assets | |||||
Total Assets | 75.9 | 243 | 299 | 198 | 143 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 10.2 | 10.2 | 13.1 | 15.6 | 18.6 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 27.6 | 26.3 | 48.8 | 47.4 | 46.2 |
Redeemable Preferred Stock | |||||
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Total Equity | 48.3 | 216 | 251 | 151 | 96.7 |
Total Liabilities & Shareholders' Equity | 75.9 | 243 | 299 | 198 | 143 |
Total Common Shares Outstanding |